Accelerate Diagnostics
AXDX
$5.49
Share price
-2.14%
Change (1 day)
205.00%
Change (1 year)
Categories
Market capitalization of Accelerate Diagnostics (AXDX)
Market cap: $78.88 Million
As of September 2023 Accelerate Diagnostics has a market cap of $78.88 Million. This makes Accelerate Diagnostics the world's 7135th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Accelerate Diagnostics from 2001 to 2023
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2023 | $78.88 M | 12.74% |
| 2022 | $69.96 M | -80.76% |
| 2021 | $0.36 B | -16.72% |
| 2020 | $0.43 B | -52.77% |
| 2019 | $0.92 B | 48.25% |
| 2018 | $0.62 B | -57.03% |
| 2017 | $1.45 B | 35.99% |
| 2016 | $1.06 B | -2.98% |
| 2015 | $1.10 B | 28.42% |
| 2014 | $0.85 B | 68.59% |
| 2013 | $0.50 B | 397.73% |
| 2012 | $0.10 B | 659.86% |
| 2011 | $13.43 M | 26.15% |
| 2010 | $10.64 M | 23.98% |
| 2009 | $8.59 M | -63.48% |
| 2008 | $23.52 M | -49.05% |
| 2007 | $46.16 M | 131.5% |
| 2006 | $19.94 M | -34.21% |
| 2005 | $30.31 M | 44.91% |
| 2004 | $20.91 M | -1.77% |
| 2003 | $21.29 M | 56.06% |
| 2002 | $13.64 M | -15.99% |
| 2001 | $16.24 M |
End of Day market cap according to different sources
On Sep 24th, 2023 the market cap of Accelerate Diagnostics was reported to be:
$80.6 Million
$80.6 Million
$80.6 Million
$80.6 Million
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | $194.81 B | 246,871.78% | 🇺🇸 USA |
 Becton Dickinson BDX | $77.10 B | 97,645.88% | 🇺🇸 USA |
 PerkinElmer
PKI | $14.45 B | 18,226.27% | 🇺🇸 USA |
 Bruker BRKR | $9.23 B | 11,611.14% | 🇺🇸 USA |
 NanoString Technologies NSTG | $78.92 M | 0.05% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | $10.33 B | 13,003.33% | 🇺🇸 USA |